WO2017000089A1 - Procédé d'amélioration biotechnologique pour l'obtention de raisins sans pépins antiviraux - Google Patents

Procédé d'amélioration biotechnologique pour l'obtention de raisins sans pépins antiviraux Download PDF

Info

Publication number
WO2017000089A1
WO2017000089A1 PCT/CN2015/000519 CN2015000519W WO2017000089A1 WO 2017000089 A1 WO2017000089 A1 WO 2017000089A1 CN 2015000519 W CN2015000519 W CN 2015000519W WO 2017000089 A1 WO2017000089 A1 WO 2017000089A1
Authority
WO
WIPO (PCT)
Prior art keywords
medium
antiviral
embryo
grape
seedless
Prior art date
Application number
PCT/CN2015/000519
Other languages
English (en)
Chinese (zh)
Inventor
田莉莉
牛良
Original Assignee
中国农业科学院郑州果树研究所
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 中国农业科学院郑州果树研究所 filed Critical 中国农业科学院郑州果树研究所
Publication of WO2017000089A1 publication Critical patent/WO2017000089A1/fr

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8283—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for virus resistance
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H4/00—Plant reproduction by tissue culture techniques ; Tissue culture techniques therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression

Definitions

  • the invention belongs to the technical field of agricultural biotechnology breeding, and particularly relates to a biotechnology breeding method for obtaining antiviral seedless grapes.
  • Grape is one of the oldest fruit tree species in the world. It is popular among domestic and foreign consumers for its succulent, nutritious and multi-health functions. In recent years, the demand for table grape varieties in the domestic and foreign markets has also come. The higher, especially the non-nuclear grapes are more and more popular, and the existing seedless grape varieties can no longer meet the production needs. At the same time, grapes are also the most fruit species of the virus species [Martelli et al. Grapevine virology highlights: 2010-2012. Proceedings of the 17th Congress of ICVG, Davis, Califomia, USA, 2012: 13-31]. In recent years, grapes have been developed in various parts of China, and introductions have been frequent between regions.
  • RNAi vectors constructed by transforming all or part of the viral coat protein gene can obtain disease-resistant transgenic plants [Zhu Changxiang et al. Cultivation of PVY, TMV and CMV Transgenic Tobacco. China Agricultural Sciences, 2008, 41(4): 1040-1047].
  • RNAi vectors Most researchers in the construction of RNAi vectors usually select relatively conserved fragments in the viral genome as interference fragments, which can also reduce the loss of disease resistance of transgenic plants caused by viral mutations [Xu et al. conserved sequences of replicas gene- Mediated resistance to Potyvirus through RNA silencing. Journal of Plant Biology, 2009, 52(6): 550-559].
  • the commonly used method of embryo rescue technology to cultivate seedless grape has some inadequacies: most of the non-nuclear grapes cultivated in production belong to the Eurasian species, although the quality is good but the disease resistance is generally poor. It is easy to obtain “nuclear-free ⁇ non-nuclear” non-nuclear offspring, but the obtained non-nuclear grapes are often less resistant to disease than the parents, and are more vulnerable to various viruses in nature. Therefore, relying solely on embryos to save this single organism The non-nuclear grapes obtained by technical means have great defects in antiviral diseases.
  • the object of the present invention is to provide a biotechnology breeding method for obtaining antiviral seedless grape.
  • the embryo rescue technology and the transgenic two biotechnology methods are organically fused in the non-nuclear grape hybrid embryo.
  • the embryoid body induced by the zygotic embryo with the non-nuclear gene is used as a transgenic receptor material, and an RNAi antiviral vector containing the viral coat protein gene is introduced to obtain an antiviral disease.
  • Nuclear grape regeneration plant new material is used.
  • the technical solution adopted by the invention is a biotechnology breeding method for obtaining antiviral seedless grapes, comprising the following steps:
  • Step 1 Obtaining a grape zygotic embryo with a non-nuclear gene by crossing between the seedless grape varieties and embryo rescue;
  • Step 2 Inducing the growth of grape somatic embryos by zygotic embryos
  • Step 3 Construct an RNAi antiviral plant expression vector and transfer it to Agrobacterium tumefaciens;
  • Step 4 Agrobacterium transforms the somatic embryo derived from the zygotic embryo to obtain a regenerated plant.
  • the invention also features:
  • step 1 the grape zygotic embryo with the non-nuclear gene obtained by hybridization and embryo rescue of the seedless grape variety is specifically:
  • Step 1.1 Artificial emasculation of the female parent species 3 days before flowering, the inflorescences after emasculation are immediately sprayed clean with water and bagged and tagged;
  • Step 1.2 On the 2-3rd day after the emasculation, the father's pollen is collected by the brush and scattered on the stigma of the female parent for artificial pollination;
  • Step 1.3 After 6 weeks of pollination, the young fruit was collected in the field, rinsed with tap water for 10 min; soaked in 70% alcohol for 1 minute on the ultra-clean workbench, then immersed in 0.1% HgCl 2 for 8 minutes, rinsed 4 times with sterile water. ;
  • Step 1.4 The sterilized fruit pieces are placed in a sterilized culture dish, and the ovules are taken out under aseptic conditions, and inoculated on the zygotic embryo development medium for ovule endogenous culture, and the zygotic embryo development medium is solid-liquid two-phase. TL medium;
  • Step 1.5 After the ovule is cultured on the zygotic embryo development medium for 6 weeks, the developing immature embryos are taken out under aseptic conditions, and inoculated on the solid embryogenic callus induction medium; that is, the grape zygotic embryo with the non-nuclear gene is obtained. .
  • composition and content of TL medium are as follows: calcium nitrate 250.0 mg / L, potassium nitrate 600.0 mg / L, potassium chloride 75.0 mg / L, ammonium nitrate 300.0 mg / L, magnesium sulfate 1200.0 mg / L, potassium dihydrogen phosphate 300.0mg/L, manganese sulfate 3.0mg/L, potassium iodide 0.8mg/L, boric acid 0.5mg/L, zinc sulfate 0.5mg/L, sodium selenite 0.25mg/L, cobalt chloride 0.025mg/L, copper sulfate 0.025mg/L, sodium molybdate 0.025mg/L, ferric citrate 10.0mg/L, thiamine hydrochloride 0.25mg/L, pyridoxine hydrochloride 0.25mg/L, D-pantothenate 0.25mg/L, nicotinic acid 0.25m
  • step 2 the somatic embryos induced by zygotic embryos are specifically:
  • Step 2.1 inoculation of the hybrid zygotic embryo obtained in step 1 on a solid embryogenic callus induction medium
  • Step 2.2 After the zygotic embryo is cultured on the embryogenic callus induction medium for 4 weeks, the obtained yellow, granular, and compact embryogenic callus is inoculated on the solid somatic embryo differentiation medium;
  • Step 2.3 After the embryogenic callus is cultured on the somatic embryo differentiation medium for 4 weeks, a large number of somatic embryos can be induced, and at this time, most somatic embryo development stages are in the cotyledon stage.
  • the composition of the embryogenic callus induction medium in step 2.1 is TL+0.5mg/L6-BA+1.0mg/L 2,4-D, wherein sucrose 30g/L and agar 6.0g/L are added; step 2.3
  • the composition of the medium somatic embryo differentiation medium was TL+0.5 mg/L 6-BA+2.0 mg/L NAA, wherein 30 g/L of sucrose and 6.0 g/L of agar were added.
  • RNAi antiviral plant expression vector is constructed in step 3 and transferred to Agrobacterium tumefaciens:
  • RNAi interference fragment GV is GFLV, GLRaV-3, GVA and GVB
  • SEQ ID NO. 1 The 825 bp large fragment obtained by sequential concatenation of the four grape virus coat protein genes was sequenced in SEQ ID NO. 1; PCR amplification was carried out with GV upstream primer GV-F and downstream primer GV-R added with linker CACC. The PCR product was subjected to 1.0% agarose gel electrophoresis and the target band was cut and recovered to obtain the blunt-end PCR product containing the interference fragment GV; 6 ⁇ L of the ligation reaction system was constructed, and the reaction was carried out at 25 ° C for 30 min, and the product was transformed by heat shock method.
  • Step 3.2 Construction of RNAi vector: LR reaction of the entry vector pENTR-GV and the target vector pHELLSGATE12 to construct a 20 ⁇ L LR reaction system; after reacting at 25 ° C for 12 h, the reaction was terminated by adding proteinase K; the reaction product was heat-transformed into E. coli Top10 Competent cells were uniformly coated on LB medium plates containing 100 mg/L spectinomycin (Spec), inverted culture at 37 ° C for 16 h, and monoclonal cloned into LB liquid medium containing the same concentration of Spec in shaking culture at 37 ° C for 14 h.
  • Spec spectinomycin
  • the plasmid was digested with Xho I and Xba I, and the pHELLSGATE12 was used as a control.
  • the recombinant plasmid after LR reaction was digested with Xho I and Xba I, and the fragment size was 917 bp and 915 bp, respectively.
  • the recombinant plasmid was constructed as RNAi vector and named PH12- GV;
  • Step 3.3 RNAi vector transformation Agrobacterium tumefaciens: The PH12-GV vector was transformed into Agrobacterium strain EHA105 competent cells, and uniformly coated on YEB plate medium containing 50 mg/L rifampicin and 100 mg/L spectinomycin, 28 Incubate for 48 h under °C conditions, pick the monoclonal to the same concentration of rifampicin and spectinomycin in YEB liquid medium for 28 h at 28 °C, and use GV-F and GV-R as primers for PCR amplification. After electrophoresis on a 1.0% agarose gel, the PCR product was a 829 bp fragment, and the RNAi plant expression vector engineering strain was transformed and named EH-GV.
  • the sequence of the GV-F upstream primer GV-F is shown in SEQ ID NO. 2, specifically: CACCATGGGTGATGAGCTTTGATGC; the sequence of the downstream primer of the GV is shown in SEQ ID NO. 3, specifically: TAGACTCTCAAGCTTGCTAA;
  • the PCR reaction system in step 3.1 and step 3.3 is: 10 ⁇ Buffer 5 ⁇ L, dNTP mixtuer 5 ⁇ L, 10 ⁇ mol/L GV-F 2 ⁇ L, 10 ⁇ mol/L GV-R 2 ⁇ L, Pfu DNA Polymerase 1 ⁇ L, template 1 ⁇ L, sterilization double 34 ⁇ L of distilled water, the total volume of 50 ⁇ L; PCR reaction parameters: pre-denaturation at 94 °C for 5min; denaturation at 94 °C for 30s, annealing at 56 °C for 30s, extension at 72 °C for 40s, a total of 35 cycles; 72 °C extension for 10min;
  • M13-F The sequence of M13-F is shown in SEQ ID NO. 4, specifically: GTAAAACGACGGCCAGT.
  • the ligation reaction system used in step 3.1 is: recovery of the target gene fragment GV 1 ⁇ L, salt solution 1 ⁇ L, pENTR TM /SD/ Vector 1 ⁇ L, 3 ⁇ L of sterile ultrapure water.
  • the Xba I digestion system in step 3.2 is: Xba I 1 ⁇ L, 10 ⁇ M Buffer 2 ⁇ L, 0.1% BSA 2 ⁇ L, LR reaction product 6 ⁇ L, sterile ultrapure water 9 ⁇ L;
  • Xho I digestion system Xho I 1 ⁇ L, 10 ⁇ H Buffer 2 ⁇ L, LR reaction product 6 ⁇ L, and sterile ultrapure water 11 ⁇ L.
  • the LR reaction system in the step 3.2 was: pENTR-GV 2 ⁇ L, pHELLSGATE 12, 2 ⁇ L, LR clonase enzyme mix 4 ⁇ L; Sterile water 12 ⁇ L.
  • step 4 the Agrobacterium-derived zygotic embryo-derived somatic embryos obtain regenerated plants as follows:
  • Step 4.1 at 28 ° C, 200 rpm, the RNAi plant expression vector engineering strain EH-GV transformed with Agrobacterium was shake cultured in YEB liquid medium containing 50 mg/L rifampicin for 48 hours until the OD value was about 0.5. After centrifugation at 5000 rpm for 10 minutes, the precipitated cells were collected, resuspended in an equal volume of WPM liquid medium, and the somatic embryo obtained in step 2.3 was inoculated with Agrobacterium liquid for 10-15 minutes;
  • Step 4.2 The infected somatic embryo is placed in a sterile culture dish, and the excess bacterial solution is blotted with the sterile filter paper, inoculated on the WPM solid medium, and cultured for 3 days in the dark;
  • Step 4.3 after inoculation of the infected somatic embryos in WPM + 0.2 mg / L 6 - BA + 50 mg / L kanamycin (Kan) + 200 mg / L cephalosporin (Cef) + 200 mg / L carbenicillin (Carb) medium, cultured for 3 months under the conditions of 16h/8h photoperiod, once every 2 weeks;
  • Step 4.4 cultivating the resistant bud obtained by germination on 1/2MS+0.2mg/L ⁇ butyric acid (IBA)+25mg/L Kan+200mg/L Cef+200mg/L Carb medium at 16h/8h light Incubate for 2 months under cyclic conditions, subculture every 4 weeks, and the tube seedlings after rooting are expanded on 1/2MS+0.2mg/L IBA+25mg/L Kan+200mg/L Cef+200mg/L Carb medium. Regenerated plants with strong growth and good rooting are cultivated and transplanted in the greenhouse to prepare antiviral seedless grapes.
  • IBA 1/2MS+0.2mg/L ⁇ butyric acid
  • the beneficial effects of the present invention are as follows: the "endosome embryo" of the acceptor material used for Agrobacterium infection in the transformation of grapes of the present invention is induced by the zygotic embryo of the "nuclear-free ⁇ non-nuclear” grape hybrid, which is contained in the acceptor material.
  • the ratio of non-nuclear genes is high ( ⁇ 80%), so it is easier to obtain antiviral non-nuclear materials in transformed plants after transformation.
  • the main advantages of the RNAi antiviral vector used in the transformation of the grape of the present invention are: (1) the complete gene of the virus is not required, and only the partial fragment of the gene can also play a disease resistance; (2) The inserted gene fragment is small, which is conducive to vector construction and genetic transformation; (3) RNA invading the virus in the transgenic plant is rapidly degraded, and the virus gene is not required to express the protein, and the transgenic product is more safe and reliable; (4) single copy transformation It also produces highly resistant and even immune plants.
  • the invention combines the seedless grape embryo rescue technology with the transgenic technology, adopts the embryoid body of the seedless grape hybrid immature embryo obtained by embryo rescue as the acceptor material, and utilizes the conserved fragment containing the grape virus coat protein (CP) gene.
  • the RNAi antiviral vector is subjected to Agrobacterium-mediated genetic transformation, and a new grape material which is both antiviral and non-nuclear can be obtained from the transformed plant after transformation, and a new variety is selected.
  • Figure 1 is the PCR identification of the entry cloning vector pENTR-GV, wherein M: DL2000 marker; 1: pENTR-GV with M13-F & GV-R as primer PCR amplification results; 2: pENTR-GV with GV-F & GV-R as primer PCR amplification results;
  • Figure 2 is a Xho I digestion of the RNAi vector PH12-GV; wherein, M: DL2000 marker; 1: PH12-GV digestion results; 2: pHELLSGATE12 no-load digestion results;
  • Figure 3 is a Xba I digestion of the RNAi vector PH12-GV of the present invention, wherein M: DL2000 marker; 1: PH12-GV digestion results; 2: pHELLSGATE12 empty-cut digestion results;
  • Figure 4 is a PCR identification of EH-GV of the present invention. wherein, M: DL2000 marker; 1: EHA105 no-load PCR result; 2-3: PCR result of EH-GV engineering strain;
  • Figure 5 is a regenerated plant of the somatic embryo derived from the Agrobacterium EH-GV transformed zygotic embryo of the present invention, wherein D-1: somatic embryo after infection by Agrobacterium, D-2: post-embryonic germination of Agrobacterium transformant cells Resistant bud, D-3: Regenerated plant of post-embryo rooting of Agrobacterium tumefaciens cells, D-4: Transgenic plants transplanted into the greenhouse.
  • Example 1 Obtaining a grape zygotic embryo with a non-nuclear gene by hybridization and embryo rescue between seedless grape varieties:
  • Step A-1 artificial emasculation of the female cultivar 3 days before flowering (the female parent in this example is “red-faced non-nuclear”), and the inflorescences after emasculation are immediately sprayed with water and bagged and tagged. ;
  • Step A-2 On the 2-3rd day after emasculation, the father's pollen is taken with a writing brush (in this embodiment, the male parent is "flame without nuclear") scattered on the female stigma for artificial pollination;
  • Step A-3 6 weeks after pollination, collect young fruit in the field, rinse with tap water for 10 minutes; soak it in 70% alcohol for 1 minute on the ultra-clean workbench, then soak it in 0.1% HgCl 2 for 8 minutes, rinse with sterile water. 4 times;
  • Step A-4 the disinfected fruit pieces are placed in a sterile culture dish, and the ovules are taken out under aseptic conditions, and inoculated on the zygotic embryo development medium for ovule endogenous culture, and the zygote embryo development medium is solid-liquid double Phase TL medium, its composition and content are as follows: calcium nitrate 250.0mg / L, potassium nitrate 600.0mg / L, potassium chloride 75.0mg / L, ammonium nitrate 300.0mg / L, magnesium sulfate 1200.0mg / L, phosphoric acid Potassium dihydrogen 300.0mg / L, manganese sulfate 3.0mg / L, potassium iodide 0.8mg / L, Boric acid 0.5mg/L, zinc sulfate 0.5mg/L, sodium selenite 0.25mg/L, cobalt chloride 0.025mg/L, copper sulfate
  • Step A-5 after the ovule is cultured on the zygotic embryo development medium for 6 weeks, the developing immature embryos are taken out under aseptic conditions, and inoculated on the solid embryogenic callus induction medium, the embryogenic callus induction medium.
  • the composition is TL+0.5mg/L6-BA+1.0mg/L 2,4-D, with 30g/L of sucrose and 6.0g/L of agar; the gene with no nuclear gene (the ratio is above 80%) can be obtained. Grape zygotic embryo.
  • Step B-1 the hybrid zygotic embryo obtained in the step A is inoculated on the solid embryogenic callus induction medium, and the composition of the embryogenic callus induction medium is TL+0.5 mg/L 6-BA+1.0 mg. /L 2,4-D, wherein sucrose 30g / L, agar 6.0g / L;
  • Step B-2 After the zygotic embryo is cultured on the embryogenic callus induction medium for 4 weeks, the obtained yellow, granular, and compact embryogenic callus is inoculated on the solid somatic embryo differentiation medium.
  • the composition of the somatic embryo differentiation medium is TL+0.5 mg/L 6-BA+2.0 mg/L NAA, wherein 30 g/L of sucrose and 6.0 g/L of agar are added;
  • Step B-3 after the embryogenic callus is cultured on the somatic embryo differentiation medium for 4 weeks, a large number of somatic embryos can be induced.
  • most of the somatic embryo development stages are in the cotyledon stage. .
  • Step C-1 the construction process of the entry cloning vector
  • the RNAi interference fragment GV is 825 bp obtained by sequentially concatenating the conserved segments of the four grape virus coat protein genes of GFLV, GLRaV-3, GVA and GVB. Large fragment (see SEQ ID NO. 1 for the sequence).
  • PCR amplification was carried out using the GV upstream primer GV-F (the primer sequence is CACCATGGGTGATGAGCTTTGATGC, the sequence is shown in SEQ ID NO. 2) and the downstream primer GV-R (the primer sequence is TAGACTCTCAAGCTTGCTAA, the sequence is shown in SEQ ID NO. 3).
  • the PCR reaction system in this example is: 10 ⁇ Buffer 5 ⁇ L, dNTP mixtuer (2.5 mM of each dNTP) 5 ⁇ L, GV-F (10 ⁇ mol/L) 2 ⁇ L, GV-R (10 ⁇ mol/L) 2 ⁇ L, Pfu DNA Polymerase 1 ⁇ L, 1 ⁇ L of template, sterile double distilled water 34 ⁇ L, total volume 50 ⁇ L.
  • the PCR reaction parameters were: pre-denaturation at 94 ° C for 5 min; (degeneration at 94 ° C for 30 s, annealing at 56 ° C for 30 s, extension at 72 ° C for 40 s) for 35 cycles; 72 ° C for 10 min.
  • the PCR product was subjected to 1.0% agarose gel electrophoresis and the target strip was recovered to obtain a blunt-end PCR product containing the interference fragment (GV).
  • GV interference fragment
  • kit instructions were used to construct a 6 ⁇ L reaction system.
  • the reaction system used in this example was: Recovering the target gene fragment GV 1 ⁇ L, salt solution 1 ⁇ L, pENTR TM /SD/ Vector 1 ⁇ L, sterile ultrapure water 3 ⁇ L), reacted at 25°C for 30min, and the product was heat-induced to transform E. coli Top10 competent cells and evenly coated on LB solid medium plate containing 75mg/L kanamycin.
  • the PCR reaction system in this example is: 10 ⁇ Buffer 2 ⁇ L, dNTP mixtuer (2.5 mM of each dNTP) 1.6 ⁇ L, primer (10 ⁇ mol/L) 1 ⁇ L each 1 ⁇ L, rTaq DNA Polymerase 0.2 ⁇ L, template 1 ⁇ L, sterile double distilled water 13.2 ⁇ L, total volume 20 ⁇ L.
  • the PCR reaction parameters are the same as in step C-1.
  • Step C-2 RNAi vector construction process: The entry vector pENTR-GV and the target vector pHELLSGATE12 were subjected to LR reaction, and 20 ⁇ L reaction system was constructed according to the Gateway LR Clonase II Enzyme Mix kit instructions.
  • the reaction system of this example was: pENTR-GV 2 ⁇ L, pHELLSGATE 12, 2 ⁇ L, LR clonase enzyme mix 4 ⁇ L, Sterile water 12 ⁇ L. After 12 h of reaction at 25 ° C, the reaction was stopped by the addition of proteinase K. The reaction product was heat-transformed into E.
  • coli Top10 competent cells uniformly coated on LB medium plate containing 100 mg/L spectinomycin, inverted culture at 37 ° C for 16 h, and picked up to LB liquid medium containing the same concentration of Spec. After incubating for 14 h at 37 ° C, the plasmid was extracted and then digested with Xho I (Fig. 2) and Xba I (Fig. 3) (with pHELLSGATE12 empty control as control).
  • the Xba I digestion system was: Xba I 1 ⁇ L, 10x M Buffer 2 ⁇ L, 0.1% BSA2 ⁇ L, LR reaction product 6 ⁇ L, sterile ultrapure water 9 ⁇ L;
  • Xho I digestion system Xho I 1 ⁇ L, 10x H Buffer 2 ⁇ L, LR reaction product 6 ⁇ L, sterilized ultrapure water 11 ⁇ L .
  • the fragment size was about 900 bp, and the size of the fragment was significantly different from that of unreacted PHELLSGATE12 (Xho I was 1429 bp).
  • the Xba I excised fragment was 1419 bp), and it was confirmed that the recombinant plasmid was a constructed RNAi vector, which was named PH12-GV in this example.
  • Step C-3 RNAi vector transformation of Agrobacterium tumefaciens
  • transforming PH12-GV vector into Agrobacterium strain EHA105 competent cells uniformly coated on YEB plate containing 50 mg/L rifampicin and 100 mg/L spectinomycin
  • On the base incubate at 48 °C for 48 h, pick the monoclonal to the same concentration of rifampicin and spectinomycin in YEB liquid medium for 28 h at 28 °C, and use GV-F&GV-R as primer to carry out bacterial PCR amplification.
  • Increase, 1.0% agarose gel electrophoresis, PCR reaction system and reaction parameters are the same as step C-1.
  • Example 4 Agrobacterium transforms zygotic embryo-derived somatic embryos to obtain regenerated plants
  • Step D-1 28 ° C, 200 rpm
  • the RNAi plant expression vector engineering strain EH-GV transformed with Agrobacterium was shake cultured in YEB liquid medium containing 50 mg/L rifampicin for 48 hours until the OD value was about
  • the precipitated cells were collected, resuspended in an equal volume of WPM liquid medium, and the somatic embryos obtained in the step B-3 were inoculated with Agrobacterium liquid for 10-15 minutes.
  • Step D-2 the infected somatic embryos are placed in a sterile culture dish, and the excess bacterial solution is blotted with the sterilized filter paper, inoculated on a WPM solid medium, and cultured for 3 days in the dark.
  • Step D-3 after inoculation of the infected somatic embryos in WPM + 0.2 mg / L 6 - BA + 50 mg / L kanamycin (Kan) + 200 mg / L cephalosporin (Cef) + 200 mg / L carboxy
  • Kan kanamycin
  • Cef cephalosporin
  • the cells were cultured on benzylpenicillin (Carb) medium for 3 months under the conditions of 16 h/8 h photoperiod, and subcultured every 2 weeks.
  • Step D-4 culturing the resistant bud obtained by germination in 1/2MS+0.2mg/L indolebutyric acid (IBA)+25mg/L kanamycin (Kan)+200mg/L Cef+200mg/L Carb culture
  • IBA indolebutyric acid
  • Kan kanamycin
  • the test tube seedlings after rooting were 1/2MS+0.2mg/L IBA+25mg/L Kan+200mg/L Cef+200mg/LCarb
  • the regenerated plants with strong growth and good rooting are selected for refining and transplanting in the greenhouse.
  • the plants with good root development under in vitro conditions are washed with water after being reheated in the greenhouse.
  • the attached agar is transplanted into a nutrient bowl containing nutrient soil, and the lived seedlings are routinely managed to develop into a robust grape plant.
  • Step E-2 After surface disinfection of the leaves with 70% alcohol, dry them thoroughly. After rubbing the upper surface of the leaves with quartz sand to make a slight wound, use the fingers to pick up the virus extract and inoculate the seeds into the young leaves of the grapes. The plants were inoculated with 5 leaves, and the untransformed plants were inoculated as a control. After 20 days, the plants were tested with DAS-ELISA.
  • Step E-3 take 100 mg of the top leaves of the test plants, grind in 1 ml of PBS buffer, centrifuge, and take the supernatant, and dilute the antibody to 1 g with 0.1 mol/L (pH 9.6) carbonate coating buffer.
  • Table 1 show that the control plants showed a susceptibility response to the four viruses after virus inoculation, and the transgenic plants obtained after transformation showed the disease resistance reaction in most cases.
  • the strains TrGV-1, TrGV-3, and TrGV-4 showed the most serious four viruses (GFLV, GLRaV-3, GVA, GVB) in grape production.
  • the reaction; the strain TrGV-2 showed only a disease for the virus GVB, but showed resistance to the other three viruses. It indicated that the virus accumulation of these transgenic plants was significantly reduced after inoculation of the virus, and thus the disease resistance was significantly improved.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Botany (AREA)
  • Environmental Sciences (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)

Abstract

L'invention concerne un procédé d'amélioration biotechnologique permettant d'obtenir des raisins antiviraux sans pépins. Le procédé comprend les étapes consistant à : obtenir des embryons zygotiques contenant des gènes d'absence de pépins en effectuant une hybridation entre des variétés de raisins sans pépins et une récupération d'embryon, et en induisant une embryogenèse somatique de raisins au moyen des embryons zygotiques ; et effectuer une transformation génétique exercée par Agrobacterium tumefaciens à l'aide de vecteurs antiviraux d'ARNi contenant des segments de gène conservateur de la protéine de capside du virus de raisin (CP), ce qui permet d'obtenir un matériel de raisin qui est à la fois antiviral et sans pépins à partir de plantes de régénération transformées.
PCT/CN2015/000519 2015-06-30 2015-08-12 Procédé d'amélioration biotechnologique pour l'obtention de raisins sans pépins antiviraux WO2017000089A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201510377125.0A CN104988179A (zh) 2015-06-30 2015-06-30 一种获得抗病毒无核葡萄的生物技术育种方法
CN201510377125.0 2015-06-30

Publications (1)

Publication Number Publication Date
WO2017000089A1 true WO2017000089A1 (fr) 2017-01-05

Family

ID=54300073

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2015/000519 WO2017000089A1 (fr) 2015-06-30 2015-08-12 Procédé d'amélioration biotechnologique pour l'obtention de raisins sans pépins antiviraux

Country Status (2)

Country Link
CN (1) CN104988179A (fr)
WO (1) WO2017000089A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111909953A (zh) * 2020-06-05 2020-11-10 东北林业大学 用于桑黄遗传表达的重组载体及构建方法和遗传转化方法
CN114686492A (zh) * 2020-12-31 2022-07-01 哈尔滨师范大学 紫花苜蓿的MsbHLH115基因的应用和含有MsbHLH115基因的重组载体
CN114717175A (zh) * 2022-04-11 2022-07-08 中国热带农业科学院橡胶研究所 一种建立具有高体胚发生能力橡胶树胚性细胞纯系以及维持其胚性形态的方法
CN115211370A (zh) * 2022-08-18 2022-10-21 西北农林科技大学 一种赤霞珠葡萄花器官愈伤组织诱导培养基及培养方法
CN117487847A (zh) * 2023-10-31 2024-02-02 中国热带农业科学院橡胶研究所 一种获得橡胶树纯合基因编辑植株的方法

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109906868A (zh) * 2019-04-03 2019-06-21 新疆农业科学院园艺作物研究所 一种葡萄新品种快速培育的方法
CN109880833A (zh) * 2019-04-19 2019-06-14 西北农林科技大学 能有效减少种子形成的基因及其在培育无核植物中的应用
CN111733171B (zh) * 2020-06-23 2022-02-25 中国农业科学院郑州果树研究所 抗根癌病的靶基因片段及其干扰载体和应用
CN112126646B (zh) * 2020-09-28 2022-07-19 西北农林科技大学 用于植物抗葡萄卷叶病毒-3的sgRNA、载体、宿主细胞及方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1415189A (zh) * 2002-08-05 2003-05-07 西北农林科技大学 一种抗病无核葡萄高效聚合育种方法
CN1896227A (zh) * 2006-06-26 2007-01-17 西北农林科技大学 提高抗病无核葡萄胚挽救育种效率的双相培养基及制备方法
CN101564011A (zh) * 2009-05-18 2009-10-28 杭州蓝天园林建设集团有限公司余杭分公司 一种欧亚种无核葡萄高效育种技术
CN101982065A (zh) * 2010-09-07 2011-03-02 河北科技师范学院 一种简化无核葡萄胚挽救的方法
CN103181321A (zh) * 2013-03-07 2013-07-03 西北农林科技大学 一种抗寒无核葡萄育种的方法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1415189A (zh) * 2002-08-05 2003-05-07 西北农林科技大学 一种抗病无核葡萄高效聚合育种方法
CN1896227A (zh) * 2006-06-26 2007-01-17 西北农林科技大学 提高抗病无核葡萄胚挽救育种效率的双相培养基及制备方法
CN101564011A (zh) * 2009-05-18 2009-10-28 杭州蓝天园林建设集团有限公司余杭分公司 一种欧亚种无核葡萄高效育种技术
CN101982065A (zh) * 2010-09-07 2011-03-02 河北科技师范学院 一种简化无核葡萄胚挽救的方法
CN103181321A (zh) * 2013-03-07 2013-07-03 西北农林科技大学 一种抗寒无核葡萄育种的方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
TIAN, LILI ET AL.: "Construction of Binary RNAi Expression Vector with Virus Resistance and Genetic Transformation in Tobacco", JOURNAL OF FRUIT SCIENCE, vol. 29, no. 6, 31 December 2012 (2012-12-31) *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111909953A (zh) * 2020-06-05 2020-11-10 东北林业大学 用于桑黄遗传表达的重组载体及构建方法和遗传转化方法
CN111909953B (zh) * 2020-06-05 2023-07-07 东北林业大学 用于桑黄遗传表达的重组载体及构建方法和遗传转化方法
CN114686492A (zh) * 2020-12-31 2022-07-01 哈尔滨师范大学 紫花苜蓿的MsbHLH115基因的应用和含有MsbHLH115基因的重组载体
CN114686492B (zh) * 2020-12-31 2023-08-01 哈尔滨师范大学 紫花苜蓿的MsbHLH115基因的应用和含有MsbHLH115基因的重组载体
CN114717175A (zh) * 2022-04-11 2022-07-08 中国热带农业科学院橡胶研究所 一种建立具有高体胚发生能力橡胶树胚性细胞纯系以及维持其胚性形态的方法
CN115211370A (zh) * 2022-08-18 2022-10-21 西北农林科技大学 一种赤霞珠葡萄花器官愈伤组织诱导培养基及培养方法
CN115211370B (zh) * 2022-08-18 2023-09-01 西北农林科技大学 一种赤霞珠葡萄花器官愈伤组织诱导培养基及培养方法
CN117487847A (zh) * 2023-10-31 2024-02-02 中国热带农业科学院橡胶研究所 一种获得橡胶树纯合基因编辑植株的方法

Also Published As

Publication number Publication date
CN104988179A (zh) 2015-10-21

Similar Documents

Publication Publication Date Title
WO2017000089A1 (fr) Procédé d'amélioration biotechnologique pour l'obtention de raisins sans pépins antiviraux
Ellul et al. The expression of the Saccharomyces cerevisiae HAL1 gene increases salt tolerance in transgenic watermelon [Citrullus lanatus (Thunb.) Matsun. & Nakai.]
Lee et al. Transgenic peppers that are highly tolerant to a new CMV pathotype
CN105543269B (zh) 利用球孢白僵菌BbP4-ATPase基因提高植物对黄萎病抗性的方法
WO2017076306A1 (fr) Procédé pour améliorer la résistance des plantes à la flétrissure verticillienne en utilisant un gène d'atpase vdp4 bactérienne de la flétrissure verticillienne
CN106480163B (zh) 一种联合苹果愈伤组织细胞培养和遗传转化鉴定苹果抗病基因的方法
Krastanova et al. Resistance to crown gall disease in transgenic grapevine rootstocks containing truncated virE2 of Agrobacterium
CN105624170A (zh) OsAGO18蛋白或其编码基因在调控植物对水稻矮缩病毒或其同科病毒的抗性中的应用
CN102676564A (zh) 一种使接穗品种获得病毒抗性的方法及rna干扰载体与转基因方法
CN105647961A (zh) 一个水稻基因bsk331在提高植物耐逆性能上的应用
Chen et al. Agrobacterium-mediated genetic transformation of peanut and the efficient recovery of transgenic plants
JPWO2019103034A1 (ja) ゲノム編集植物の生産方法
CN115896160B (zh) 一种利用发根农杆菌高效快速获得苹果稳定转基因植株的方法
Kumari et al. PRSV resistance in papaya (Carica papaya L.) through genetic engineering: A review.
KR100804766B1 (ko) Ｃｍｖ 병원형 감염에 내성인 형질전환 고추
Korbin et al. Transformation of Gerbera plants with Tomato spotted wilt virus (TSWV) nucleoprotein gene
WO2021131628A1 (fr) Plante solanacée et cellule de plante solanacée ayant une résistance au virus de la maladie bronzée de la tomate, et procédé de production d'une plante solanacée
CN105968178A (zh) 水稻OsRAD1蛋白及其编码基因在调控花粉育性中的应用
Burza et al. Cucumber (Cucumis sativus L.)
CN107129997B (zh) 一种培育抗病毒转基因植物的方法及应用
Krens et al. Oriental lily hybrids engineered to resist aphid attack
CN113584055B (zh) 胡椒pnpal3基因及其在胡椒抗瘟病中的应用
CN113755519B (zh) 一种多抗筛选的杨树多基因遗传转化方法
Damiano et al. Improving regeneration and transformation for resistance to sharka in Prunus
Raghunathachari et al. Agrobacterium mediated transformation of a pure line variety of hot pepper, RCL 59M

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15896621

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15896621

Country of ref document: EP

Kind code of ref document: A1